M1 KLINIKEN AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.95 EUR | -0.83% |
|
-11.58% | +60.27% |
| 06-13 | Health Minister Lauterbach sees hospital reform on the right track | DP |
| 05-27 | M1 Kliniken AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 250.2 | 181.5 | 139.3 | 168.3 | 205.1 | 328.8 | - | - |
| Enterprise Value (EV) 1 | 241.2 | 174.9 | 95.11 | 146.9 | 205.1 | 301.9 | 308.4 | 304.4 |
| P/E ratio | 25.5 x | 25 x | 16.7 x | 41.2 x | 20.7 x | 25.8 x | 19.3 x | 16.1 x |
| Yield | 2.1% | - | - | - | - | 2.79% | 3.81% | 4.44% |
| Capitalization / Revenue | 3.24 x | 1.14 x | 0.44 x | 0.59 x | 0.65 x | 0.96 x | 0.88 x | 0.82 x |
| EV / Revenue | 3.12 x | 1.1 x | 0.3 x | 0.51 x | 0.65 x | 0.88 x | 0.83 x | 0.76 x |
| EV / EBITDA | 21.3 x | 19.7 x | 5.34 x | 9.53 x | 9.76 x | 11.6 x | 9.21 x | 7.85 x |
| EV / FCF | -35.9 x | 21.6 x | 6.63 x | 7.49 x | - | 12.9 x | 15.3 x | 12.6 x |
| FCF Yield | -2.78% | 4.63% | 15.1% | 13.3% | - | 7.73% | 6.54% | 7.95% |
| Price to Book | 3.69 x | 2 x | 1.47 x | 1.24 x | - | 3.07 x | 2.94 x | 2.78 x |
| Nbr of stocks (in thousands) | 17,500 | 19,643 | 18,580 | 18,580 | 18,315 | 18,315 | - | - |
| Reference price 2 | 14.30 | 9.240 | 7.500 | 9.060 | 11.20 | 17.95 | 17.95 | 17.95 |
| Announcement Date | 5/27/20 | 5/27/21 | 5/20/22 | 6/13/23 | 5/27/24 | - | - | - |
1EUR in Million2EUR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 77.22 | 159.6 | 314.6 | 285.3 | 316.3 | 341.4 | 371.9 | 400.9 |
| EBITDA 1 | 11.33 | 8.889 | 17.82 | 15.41 | 21.01 | 26.04 | 33.47 | 38.78 |
| EBIT 1 | 7.932 | 4.405 | 12.13 | 9.348 | 15.7 | 21.32 | 28.14 | 33.28 |
| Operating Margin | 10.27% | 2.76% | 3.86% | 3.28% | 4.96% | 6.25% | 7.57% | 8.3% |
| Earnings before Tax (EBT) 1 | 12.74 | 8.777 | 14.42 | 10.23 | 16.45 | 21.01 | 27.66 | 32.82 |
| Net income 1 | 9.729 | 6.823 | 8.905 | 4.317 | 10.27 | 13.48 | 18.08 | 21.65 |
| Net margin | 12.6% | 4.28% | 2.83% | 1.51% | 3.25% | 3.95% | 4.86% | 5.4% |
| EPS 2 | 0.5600 | 0.3700 | 0.4500 | 0.2200 | 0.5400 | 0.6950 | 0.9300 | 1.115 |
| Free Cash Flow 1 | -6.716 | 8.094 | 14.35 | 19.61 | - | 23.34 | 20.16 | 24.21 |
| FCF margin | -8.7% | 5.07% | 4.56% | 6.87% | - | 6.84% | 5.42% | 6.04% |
| FCF Conversion (EBITDA) | - | 91.06% | 80.51% | 127.23% | - | 89.65% | 60.22% | 62.44% |
| FCF Conversion (Net income) | - | 118.63% | 161.14% | 454.12% | - | 173.18% | 111.48% | 111.83% |
| Dividend per Share 2 | 0.3000 | - | - | - | - | 0.5000 | 0.6834 | 0.7973 |
| Announcement Date | 5/27/20 | 5/27/21 | 5/20/22 | 6/13/23 | 5/27/24 | - | - | - |
1EUR in Million2EUR
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2020 S1 | 2020 S2 | 2022 Q1 | 2022 Q2 | 2022 S1 | 2023 Q1 | 2023 S1 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | 29.13 | 130.5 | 63.5 | 75.17 | 138.7 | 76.8 | - |
| EBITDA | - | 5.943 | - | 3.161 | 7.361 | - | 9.947 |
| EBIT | - | 3.162 | - | 1.672 | 4.472 | - | - |
| Operating Margin | - | 2.42% | - | 2.22% | 3.23% | - | - |
| Earnings before Tax (EBT) | - | - | - | - | - | - | - |
| Net income | - | 4.786 | - | - | - | - | - |
| Net margin | - | 3.67% | - | - | - | - | - |
| EPS | 0.1200 | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - |
| Announcement Date | 8/26/20 | 5/27/21 | 7/7/22 | 10/7/22 | 10/7/22 | 8/27/23 | - |
1EUR in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - | - | - |
| Net Cash position 1 | 9.01 | 6.6 | 44.2 | 21.4 | - | 26.9 | 20.3 | 24.3 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
| Free Cash Flow 1 | -6.72 | 8.09 | 14.3 | 19.6 | - | 23.3 | 20.2 | 24.2 |
| ROE (net income / shareholders' equity) | 14.8% | 8.86% | 9.85% | 3.05% | - | 11.8% | 15.2% | 17.3% |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - | - | - |
| Book Value Per Share 2 | 3.870 | 4.620 | 5.110 | 7.280 | - | 5.850 | 6.100 | 6.450 |
| Cash Flow per Share | -0.3100 | 0.5100 | - | - | - | - | - | - |
| Capex 1 | 1.35 | 1.45 | 1.34 | 1.16 | - | 4.58 | 4.03 | 4.14 |
| Capex / Sales | 1.74% | 0.91% | 0.42% | 0.41% | - | 1.34% | 1.08% | 1.03% |
| Announcement Date | 5/27/20 | 5/27/21 | 5/20/22 | 6/13/23 | 5/27/24 | - | - | - |
1EUR in Million2EUR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
17.95
EUR
Average target price
27.5
EUR
Spread / Average Target
+53.20%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +60.27% | 354M | |
| -33.75% | 13.7B | |
| +4.15% | 11.72B | |
| -2.70% | 11.51B | |
| +8.56% | 10.56B | |
| +28.69% | 8.52B | |
| -10.32% | 7.09B | |
| +7.69% | 6.81B | |
| +8.41% | 6.48B | |
| 0.00% | 4.89B |
- Stock Market
- Equities
- M12 Stock
- Financials M1 Kliniken AG
